Will one great product make AeroVironment stock a great investment?
The Boeing Company · NYSE
Will one great product make AeroVironment stock a great investment?
AerSale Corporation previously announced the lease of a Boeing 757-200PCF freighter to Kazakhstan-based Jupiter Jet, while Boeing also secured regulatory relief to continue selling 777F freighters and gained approval as prime contractor for a US$5.75 billion JDAM-ER munitions package to Saudi Arabia. Together, these developments highlight how Boeing’s freight and defense franchises can offset pressure from ongoing 737 and 787 production challenges and cash flow constraints. Next, we’ll...
NASA awarded SpaceX three additional crewed Dragon missions, extending its ISS transportation contract through 2030 for $946 million.
Boeing (BA) stock is down about 8% over the past year and trades about 22% below its 52-week high. Inside the factories the picture reads differently: the company is delivering airplanes at a pace it has not managed since 2018, against a record order book. The upside case rests on a clear assumption: translating that delivery pace into positive free cash flow.
NASA and Boeing are discussing 10 or more additional Starliner flights in the years ahead, the Wall Street Journal reported.
Boeing Selloff Triggers BofA Response as Analyst Defends $270 Target
A new JATM framework agreement with Lockheed Martin could boost missile production and create broader opportunities across defense ETFs.
Join us in exploring the top gainers and losers within the dow jones index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Korean Air just signed a $36.2 billion Boeing commitment stretching well into the next decade, but a record backlog and blockbuster headline numbers tell only part of the story for a manufacturer still racing to prove it can actually deliver.
The contract modification covers Crew-15, Crew-16, and Crew-17, bringing SpaceX's total Commercial Crew missions to 17
BA is up +0.61%. Possible market-relevant factors below — each is coincident evidence, not a confirmed cause.